Adipocyte-Specific Deletion of Lamin A/C Largely Models Human Familial Partial Lipodystrophy Type 2.
Callie A S CorsaCarolyn M WalshDevika P BagchiMaria C Foss FreitasZiru LiJulie HardijKatrina GrangerHiroyuki MoriRebecca L SchillKenneth T LewisJessica N MaungRuth D AzariaAmy E RothbergElif A OralOrmond A MacDougaldPublished in: Diabetes (2021)
Mechanisms by which autosomal recessive mutations in Lmna cause familial partial lipodystrophy type 2 (FPLD2) are poorly understood. To investigate the function of lamin A/C in adipose tissue, we created mice with an adipocyte-specific loss of Lmna (Lmna ADKO). Although Lmna ADKO mice develop and maintain adipose tissues in early postnatal life, they show a striking and progressive loss of white and brown adipose tissues as they approach sexual maturity. Lmna ADKO mice exhibit surprisingly mild metabolic dysfunction on a chow diet, but on a high-fat diet they share many characteristics of FPLD2 including hyperglycemia, hepatic steatosis, hyperinsulinemia, and almost undetectable circulating adiponectin and leptin. Whereas Lmna ADKO mice have reduced regulated and constitutive bone marrow adipose tissue with a concomitant increase in cortical bone, FPLD2 patients have reduced bone mass and bone mineral density compared with controls. In cell culture models of Lmna deficiency, mesenchymal precursors undergo adipogenesis without impairment, whereas fully differentiated adipocytes have increased lipolytic responses to adrenergic stimuli. Lmna ADKO mice faithfully reproduce many characteristics of FPLD2 and thus provide a unique animal model to investigate mechanisms underlying Lmna-dependent loss of adipose tissues.
Keyphrases
- adipose tissue
- insulin resistance
- high fat diet induced
- high fat diet
- muscular dystrophy
- bone mineral density
- bone marrow
- metabolic syndrome
- gene expression
- type diabetes
- postmenopausal women
- skeletal muscle
- end stage renal disease
- endothelial cells
- chronic kidney disease
- physical activity
- preterm infants
- stem cells
- multiple sclerosis
- mesenchymal stem cells
- weight loss
- mental health
- newly diagnosed
- transcription factor
- duchenne muscular dystrophy
- patient reported outcomes
- peritoneal dialysis
- autism spectrum disorder